Beraprost
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Beraprost Product Information
Beraprost is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Beraprost. The product is supplied by Clearsynth under CAT No. CS-O-16971.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Beraprost
CAS No.
88430-50-6
CAT No.
CS-O-16971
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C24H30O5
Molecular Weight
398.5
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Beraprost is supplied with detailed characterization data compliant with regulatory guideline. Beraprost can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Beraprost.
Overview
"it is used as antiplatelet agent.[1] It is classified as a prostacyclin analog. As an analog of prostacyclin PGI2, beraprost affects vasodilation, which in turn lowers blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined"
Synonyms
Beraprost
Application Notes
"it is used as antiplatelet agent.[1] It is classified as a prostacyclin analog. As an analog of prostacyclin PGI2, beraprost affects vasodilation, which in turn lowers blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.